Skip to Content
Merck
CN

15369

N-Boc-ethylenediamine

≥98.0% (NT)

Synonym(s):

N-Boc-1,2-diaminoethane, tert-Butyl N-(2-aminoethyl)carbamate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
(CH3)3COCONHCH2CH2NH2
CAS Number:
57260-73-8
Molecular Weight:
160.21
UNSPSC Code:
12352116
NACRES:
NA.22
PubChem Substance ID:
57647392
MDL number:
MFCD00191871
Beilstein/REAXYS Number:
1932330
Assay:
≥98.0% (NT)

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C7H16N2O2/c1-7(2,3)11-6(10)9-5-4-8/h4-5,8H2,1-3H3,(H,9,10)

SMILES string

NCCNC(OC(C)(C)C)=O

InChI key

AOCSUUGBCMTKJH-UHFFFAOYSA-N

assay

≥98.0% (NT)

reaction suitability

reagent type: cross-linking reagent

Quality Level

200

refractive index

n20/D 1.458

bp

72-80 °C/0.1 mmHg (lit.)

density

1.012 g/mL at 20 °C (lit.)

functional group

Boc, amine

Related Categories

Application

  • Facile synthesis of new N-(aminocycloalkylene) amino acid compounds: Describes the use of N-Boc-ethylenediamine in the preparation of benzyl 2-{[2-(Boc-amino)ethyl]amino}acetate (G Matulevičiūtė et al., 2023).
  • Synthesis of a new tripod BODIPY dye: Reports on the chemical synthesis involving N-Boc-ethylenediamine for creating a BODIPY dye (H Wang et al., 2022).
  • Single‐Entity Electrocatalysis: Discusses the application of N-Boc-ethylenediamine in modifying Co3O4 nanoparticles used in electrocatalysis (T Quast et al., 2021).

Other Notes

Mono-protected derivative of ethylenediamine, preparation of pharmacologically active analogues; introduction of an ethylenediamine spacer.

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H314

Hazard Classifications

Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCN3470
BCCL7724
BCCK2568
BCCH3913
BCCG2940

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Deborah Sultan et al.
Small (Weinheim an der Bergstrasse, Germany), 14(30), e1703115-e1703115 (2018-07-03)
Focused ultrasound (FUS) technology is reported to enhance the delivery of 64 Cu-integrated ultrasmall gold nanoclusters (64 Cu-AuNCs) across the blood-brain barrier (BBB) as measured by positron emission tomography (PET). To better define the optimal physical properties for brain delivery
Russell D Viirre et al.
The Journal of organic chemistry, 68(4), 1630-1632 (2003-02-15)
An improved synthesis of ethyl N-[(2-Boc-amino)ethyl]glycinate and its hydrochloride salt is reported. The synthesis is based on the reductive alkylation of Boc-ethylenediamine with ethyl glyoxylate hydrate and furnishes the title compound in near quantitative yield and high purity without chromatography.
E Morier-Teissier et al.
Journal of medicinal chemistry, 36(15), 2084-2090 (1993-07-23)
A new molecule 4 [(GGH-DAE)2DHQ] associating the 1,4,5,8-tetrahydroxyanthraquinone ring (DHQ) of the antitumor drug mitoxantrone (2), two diaminoethylene chains (DAE), and the metal-chelating peptide Gly-Gly-His (GGH) has been synthesized. Such a molecule presents characteristics able to induce antitumor activity: compound
Synthesis of N,N-dilactitol ethylenediamine: a versatile spacer for attachment of residualizing labels to protein.
M M Dowd et al.
Analytical biochemistry, 205(2), 369-371 (1992-09-01)
Hao Li et al.
Investigative ophthalmology & visual science, 58(12), 5142-5150 (2017-10-08)
Intravitreal injection of antiangiogenic agents is becoming a standard treatment for neovascular retinal diseases. Sustained release of therapeutics by injecting colloidal carriers is a promising approach to reduce the injection frequency, which reduces treatment burdens and the risk of complications
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service